Presentations



March 2010 - Dr. Langton-Webster presented at the WBBA "Life Science Innovation Northwest" Conference in Seattle, WA.

February 2010 - Fragmentation and nuclear translocation of glyceraldehyde-3-phosphate dehydrogenase implicate initiation of apoptosis in prostate cancer cells following targeted photodynamic therapy. Tiancheng Liu, Lisa Y. Wu, Clifford E. Berkman. American Association for  Cancer Research – Cell Death Mechanisms and Cancer Therapy.  San Diego.

November 2009 - Lysosome-targeted photodynamic therapy for prostate cancer cells with a pyropheophorbide-a conjugated inhibitor of prostate-specific membrane antigen. Tiancheng Liu, Lisa Y. Wu and Clifford E. Berkman. American Association for  Cancer Research – Molecular Targets and Cancer Therapeutics. Boston.

October 2009 - Research in Prostate Cancer Detection and Treatment.  Clifford E. Berkman and Paul Benny.  Palouse Prostate Cancer Program, Pullman.

June 2009 - Phosphoramidate peptidomimetics: A new class of PSMA inhibitors as PET agents for prostate Cancer. S. E. Lapi, H. Wahnishe, D. Pham, L. Wu, T. Liu, J. Nedrow-Byers, K. Vejdani, C. E. Berkman, H. F. VanBrocklin, E. F. Jones. Society of Nuclear Medicine Annual Meeting, Toronto Canada.

A Targeted Approach to Prostate Cancer Imaging, Therapy, and Detection.  Cliff Berkman.  Invest Northwest, Seattle.

March 2009 - Targeting Prostate Cancer with Chemoaffinity Agents.  Clifford E. Berkman. Amgen, Seattle.  

January 2009 - Targeting Prostate Cancer with Chemoaffinity Agents.  Clifford E. Berkman. Fred Hutchinson Cancer Research Center,Program in Prostate Cancer Research Seminar Series, Seattle.